EA Series Trust Militia Long/Short Equity ETF ORR 深 滬
已收盤 07-18 16:00:00 美东时间
28.7957
-0.294
-1.01%
華盛通- 最 高28.94
- 今 開28.81
- 成交量 1.88万股
- 最 低 28.76
- 昨 收 29.0895
- 總市值 8264.37万
- 52周最高 30.215
- 市盈率 靜 --
- 換手率 0.66%
- 52周最低 25.63
- 委 比 75.00%
- 總股本 287.00万
- 歷史最高 30.215
- 量 比 0.38
- 振 幅 0.62%
- 歷史最低 25.63
- 每 手 1
- 風險率 0.90%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多The J.M. Smucker Co. Announces Dividend Increase
ORRVILLE, Ohio, July 16, 2025 /PRNewswire/ -- The J.M. Smucker Co. (NYSE: SJM) today announced its Board of Directors approved an increase in the quarterly dividend from $1.08 to $1.10 per c...
07-17 04:30
SELLAS gains as mid-stage trial for leukemia drug succeeds
SELLAS Life Sciences (NASDAQ:SLS) traded higher in the premarket on Tuesday after the New York-based biotech said that a Phase 2 trial that tested its antitumor agent SLS009 (tambiciclib) as part of a...
07-15 20:22
Orrstown Financial Services, Inc. Announces Date of Second Quarter 2025 Earnings Release, Conference Call and Webcast
Orrstown Financial Services, Inc. (NASDAQ: ORRF) announced that it will report second quarter 2025 earnings on July 22, 2025, after market close. A conference call and webcast to discuss the results will be held on July 23, 2025, at 9:00 am ET. Interested parties can join via webcast or by phone using the provided toll-free numbers and conference ID 5555102. A recorded playback will be available until July 30, 2025. The company, with $5.4 billion...
07-15 20:05
Sellas Life Sciences Says Phase 2 Trial Of SLS009 (Tambiciclib) Met All Primary Endpoints In Relapsed/Refractory Acute Myeloid Leukemia
The Trial Exceeded Target Overall Response Rate (ORR) of 20%, with 44% Response Rate Among Patients with Acute Myeloid Leukemia-Myelodysplasia-Related Changes (AML MR) Treated at Optimal Dose of 30 mg Twice a Week (BIW)
07-15 19:47
Why Is AbbVie Stock Trading Higher On Thursday?
AbbVie licensed IGI's trispecific myeloma drug ISB 2001 in a deal worth up to $1.925 billion following strong early-phase clinical data.
07-11 02:36
Oriole Resources Directors Increase Shareholdings, Signaling Confidence
Oriole Resources PLC ( ($GB:ORR) ) has shared an update. Oriole Resources PLC a...
07-10 17:47
中金：维持和誉-B“跑赢行业”评级 升目标价至11.3港元
中金发布研报称，维持和誉-B（02256）2025年/2026年归母净利润预测0.45亿元/3.20亿元不变。考虑到依帕戈替尼数据优异及国内注册临床进展，和...
07-10 11:10
